EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

 25.20p
   
  • Change Today:
      0.000p
  • 52 Week High: 33.45
  • 52 Week Low: 25.20
  • Currency: UK Pounds
  • Shares Issued: 453.73m
  • Volume: 1,509
  • Market Cap: £114.34m
  • Beta: 0.48

Sunday share tips: N Brown, Foxtons

By Alexander Bueso

Date: Monday 18 Oct 2021

LONDON (ShareCast) - (Sharecast News) - The Financial Mail on Sunday's Midas column touted a raft of shares which it expected would benefit from the fight against obesity as well as the associated, and sometimes fatal, health risks.
N Brown, which tailors to the more rounded and oft-ignored consumer, was the first of those, with the tipster noting that Lord Alliance, the person responsible for the retailer's success during its heyday, had recently taken back financial control.

Midas also called attention to healthy ingredients maker Treatt, which it said would benefit as interest in natural flavourings grew.

Indeed, the company was set to open a new site in Bury St Edmunds which should bolster production and help sales efforts with multinationals.

Not lost on Midas either, the firm had notched up rising dividends for 31 consecutive years.

Optibiotix shares were also worth hanging onto, despite the more recent slump in the shares.

"Investors who have hung on should probably stick with it a little longer. Gut health is a hot topic, better understanding could have a significant impact on waistlines and wellbeing and OptiBiotix is one of the few UK-listed firms in this area," Midas said.

For those suffering or at risk from diabetes, EKF Diagnostics and Renalytix AI were well placed to help too.

The former manufactures the kits used to test for diabetes while the latter - from which EKF was spun out in 2018 - helps test for those most at risk before they reach a critical stage.

EKF's shares were likely to continue to rise with the same holding true for Renalytix, although it was now awaiting regulatory approval in the States.

So for Renalytix Midas recommended taking some profits, given that the stock had more than tripled since 2019, but also told readers to "retain a good chunk, as the business has long-term potential, provided that approval comes good."

For the Gym Group on the other hand, Midas told readers to "hold" onto the shares.

"This is not the time to sell. The Government is keen to promote exercise, the Gym Group offers cut-price access to equipment and classes and its finances are sound."



'Avoid' Foxtons Sabah Meddings told readers of the Sunday Times's 'Inside the City' column.

The London-focused real-estate developer was likely to be less affected than rivals should the Chancellor not extend the stamp duty holiday, she said.

That was because most of Foxtons homes were priced at above £600,000, whereas the stamp duty holiday only applied to properties sold for less than £500,000.

Covid-19 had also seen landlords hit by falling demand for short lets shift to Foxtons, which the firm hoped to retain as long-term clients.

Foxtons was also snapping up smaller rivals in the rental market.

So too, a post-Covid boom and its focus on London might provide a boost to the company in the longer-term.

Yet in the short-term, Meddings surmised, Foxtons also faced continued stiff competition from the likes of less expensive rivals, such as Purplebricks, as well pressure on sales.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 25.20p
Change Today 0.000p
% Change 0.00 %
52 Week High 33.45
52 Week Low 25.20
Volume 1,509
Shares Issued 453.73m
Market Cap £114.34m
Beta 0.48

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.91% below the market average70.91% below the market average70.91% below the market average70.91% below the market average70.91% below the market average
75.93% below the sector average75.93% below the sector average75.93% below the sector average75.93% below the sector average75.93% below the sector average
Price Trend
53.25% below the market average53.25% below the market average53.25% below the market average53.25% below the market average53.25% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average
Income
31.8% below the market average31.8% below the market average31.8% below the market average31.8% below the market average31.8% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Growth
65.96% below the market average65.96% below the market average65.96% below the market average65.96% below the market average65.96% below the market average
54.9% below the sector average54.9% below the sector average54.9% below the sector average54.9% below the sector average54.9% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 22-Nov-2024

Time Volume / Share Price
08:25 1,509 @ 25.77p

EKF Key Personnel

CFO Stephen (Steve) Young

Top of Page